ENY2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.729200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.281800E-01
Normal-vs-Stage2
9.486800E-01
Normal-vs-Stage3
9.032400E-01
Normal-vs-Stage4
9.508800E-01
Stage1-vs-Stage2
3.505000E-01
Stage1-vs-Stage3
7.216400E-01
Stage1-vs-Stage4
6.188000E-01
Stage2-vs-Stage3
7.759800E-01
Stage2-vs-Stage4
8.685000E-01
Stage3-vs-Stage4
9.453000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.918800E-01
Normal-vs-AfricanAmerican
4.426600E-01
Normal-vs-Asian
7.263800E-01
Caucasian-vs-AfricanAmerican
4.325200E-01
Caucasian-vs-Asian
3.351200E-01
AfricanAmerican-vs-Asian
2.014800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.485400E-01
Normal-vs-Female
8.802600E-01
Male-vs-Female
3.943000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.741000E-01
Normal-vs-Age(41-60Yrs)
6.097400E-01
Normal-vs-Age(61-80Yrs)
8.481200E-01
Normal-vs-Age(81-100Yrs)
6.625000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.255900E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.698800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.070430E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.783520E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.149200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.894000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.670800E-01
Normal-vs-Daily Drinker
9.274200E-01
Normal-vs-Weekly Drinker
9.587400E-01
Normal-vs-Occasional Drinker
8.215800E-01
Normal-vs-Social Drinker
7.026800E-01
Non Drinker-vs-Daily Drinker
5.886000E-01
Non Drinker-vs-Weekly Drinker
6.858000E-01
Non Drinker-vs-Occasional Drinker
4.458800E-01
Non Drinker-vs-Social Drinker
8.828400E-01
Daily Drinker-vs-Weekly Drinker
9.353200E-01
Daily Drinker-vs-Occasional Drinker
8.525600E-01
Daily Drinker-vs-Social Drinker
4.781600E-01
Weekly Drinker-vs-Occasional Drinker
7.859600E-01
Weekly Drinker-vs-Social Drinker
5.769600E-01
Occasional Drinker-vs-Social Drinker
3.293200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.627800E-01
Normal-vs-Grade 2
9.491800E-01
Normal-vs-Grade 3
9.810000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.063000E-01
Grade 1-vs-Grade 3
9.478500E-02
Grade 1-vs-Grade 4
8.627800E-01
Grade 2-vs-Grade 3
4.565600E-01
Grade 2-vs-Grade 4
9.491800E-01
Grade 3-vs-Grade 4
9.810000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.646400E-01
Normal-vs-NonDiabetic
9.685200E-01
Diabetic-vs-NonDiabetic
7.919600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.630800E-01
Normal-vs-NoPancreatitis
9.595200E-01
Pancreatitis-vs-NoPancreatitis
6.038800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.879600E-01
Normal-vs-N1
9.313000E-01
N0-vs-N1
7.896400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.710000E-01
Normal-vs-TP53-NonMutant
4.579400E-01
TP53-Mutant-vs-TP53-NonMutant
8.16659999625102E-08
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
